ReviewBlood and lymphatic cancer : targets and therapy2022
Clinical Value of Measurable Residual Disease in Acute Lymphoblastic Leukemia.
Kyaw Hein et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
16 papers cite it
this papercites it